Bipolar Disorder Drugs And Treatment Global Market Report 2025
상품코드:1760485
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
양극성 장애 치료제 및 치료의 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 6.2%의 연평균 성장률(CAGR)을 기록하며 104억 6,000만 달러 규모에 이를 것으로 전망됩니다. 예측 기간 동안의 성장은 양극성 장애의 전 세계적인 유병률 증가, 정신건강 상태에 대한 인식 증가, 정신건강 치료의 수용 확대, 정신건강 관리에 대한 보험 적용 범위 확대, 정신건강 서비스 개선을 위한 정부의 노력 등에 기인합니다. 이 시기의 주요 동향으로는 양극성 장애 치료제 개발의 진전, 진단 방법 및 도구의 개선, 새로운 제형의 도입, 신규 치료제의 임상시험 및 연구개발 진행, 양극성 장애 치료제의 제네릭 의약품의 가용성 등을 들 수 있습니다.
정신질환의 유병률 증가는 향후 몇 년 동안 양극성 장애 치료제 및 치료 시장의 성장을 견인할 것으로 예상됩니다. 정신건강 장애는 사람의 사고, 감정, 행동 및 기분에 영향을 미치는 병적 상태로, 종종 일상 생활 기능과 전반적인 웰빙을 저해하는 경우가 많습니다. 정신건강 장애의 증가는 현대인의 라이프스타일로 인한 만성적인 스트레스에 기인하는 것으로 여겨지며, 일, 경제, 사회적 기대와 관련된 지속적인 압박이 정서적 건강에 악영향을 미쳐 장기적인 심리적 문제로 이어지고 있습니다. 양극성 장애 치료제 및 치료는 기분 변화를 안정시키고, 감정 조절을 개선하며, 이러한 장애와 관련된 파괴적인 에피소드의 빈도와 심각성을 줄이는 데 중요한 역할을 합니다. 예를 들어, 2024년 9월 미국 국립정신건강연구소(NIMH)는 2022년 미국에서 5,930만 명 이상의 성인이 정신질환(AMI)을 앓고 있으며, 이는 성인 인구의 23.1%를 차지한다고 보고했습니다. 또한, 여성은 남성보다 AMI를 경험할 가능성이 더 높았는데, 여성의 26.4%가 AMI를 경험한 반면 남성은 19.7%에 그쳤습니다. 정신질환의 증가가 지속되는 가운데 양극성 장애 치료제 및 치료에 대한 수요는 확대될 것으로 보입니다.
양극성 장애 치료제 및 치료 시장의 주요 업체들은 안정적이고 장기적인 치료 효과를 제공하는 서방형 주사제와 같은 첨단 솔루션 개발에 주력하고 있습니다. 이러한 제제는 시간이 지남에 따라 천천히 약물을 혈류로 방출하기 때문에 매일 투여할 필요가 없고 안정적인 치료 효과를 기대할 수 있습니다. 예를 들어, 2023년 1월 중국 제약사 Luye Pharma는 성인 정신분열증 및 양극성 I형 장애에 대한 장기지속형 주사제인 Rykindo(리스페리돈)의 FDA 승인을 받았습니다. 이 약은 루예파마가 개발한 독자적인 마이크로스피어 기술 플랫폼을 활용한 것으로, 2주마다 근육 주사로 투여하여 장기간 효과가 지속되는 것이 특징입니다. 유효성분인 리스페리돈은 서방형 마이크로스피어 기술을 통해 투여되기 때문에 장기간에 걸쳐 지속적으로 방출됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 양극성 장애 치료제 및 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 양극성 장애 치료제 및 치료 시장 : 성장률 분석
세계의 양극성 장애 치료제 및 치료 시장 실적 : 규모와 성장, 2019-2024년
세계의 양극성 장애 치료제 및 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 양극성 장애 치료제 및 치료 전체 시장(TAM)
제6장 시장 세분화
세계의 양극성 장애 치료제 및 치료 시장 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
기분안정제
항경련제
항정신병제
항우울제
항불안제
세계의 양극성 장애 치료제 및 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
경구
비경구
기타
세계의 양극성 장애 치료제 및 치료 시장 : 양극성 장애별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
양극성 I형 장애
양극성 II형 장애
기분 순환성 장애
세계의 양극성 장애 치료제 및 치료 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원 약국
소매 약국
온라인 약국
세계의 양극성 장애 치료제 및 치료 시장 : 기분안정제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
탄산 리튬
라모트리진
발프로산
세계의 양극성 장애 치료제 및 치료 시장 : 항경련제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
카바마제핀
옥스카바제핀
토피라메이트
세계의 양극성 장애 치료제 및 치료 시장 : 항정신병제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
올란자핀
리스페리돈
케티아핀
아리피프라졸
세계의 양극성 장애 치료제 및 치료 시장 : 항우울제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
선택적 세로토닌 재흡수 억제제(SSRI)
세로토닌·노르아드레날린 재흡수 억제제(SNRI)
삼환계 항우울제(TCA)
세계의 양극성 장애 치료제 및 치료 시장 : 항불안제 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
벤조디아제핀
부스피론
제7장 지역별·국가별 분석
세계의 양극성 장애 치료제 및 치료 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 양극성 장애 치료제 및 치료 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
양극성 장애 치료제 및 치료 시장 : 경쟁 구도
양극성 장애 치료제 및 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
Merch & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Sanofi S.A.
Bristol-Myers Squibb Company
AstraZeneca PLC
GSK PLC
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim International GmbH
Otsuka Holdings Co. Ltd.
Astellas Pharma Inc.
Sumitomo Pharma America Inc.
Dr. Reddy's Laboratories Ltd.
H. Lundbeck A/S
Cipla Limited
Gedeon Richter Plc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
양극성 장애 치료제 및 치료 시장 2029년 : 새로운 기회를 제공하는 국가
양극성 장애 치료제 및 치료 시장 2029년 : 새로운 기회를 제공하는 부문
양극성 장애 치료제 및 치료 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Bipolar disorder drugs and treatments involve a comprehensive approach aimed at managing significant mood swings and promoting long-term mental stability. This approach focuses on regulating brain function to reduce the severity and frequency of mood episodes, while also addressing related issues such as disrupted sleep, anxiety, and difficulties with concentration.
The primary treatments for bipolar disorder include mood stabilizers, anticonvulsants, antipsychotic drugs, antidepressants, and anti-anxiety medications. Mood stabilizers are designed to help maintain a stable mood, preventing the extreme highs (mania) and lows (depression) associated with bipolar disorder. These drugs can be administered through various methods, including oral, parenteral, and other routes, and are used to treat bipolar I disorder, bipolar II disorder, and cyclothymic disorder. They are available through multiple distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies.
The bipolar disorder drugs and treatment market research report is one of a series of new reports from The Business Research Company that provides bipolar disorder drugs and treatment market statistics, including bipolar disorder drugs and treatment industry global market size, regional shares, competitors with a bipolar disorder drugs and treatment market share, detailed bipolar disorder drugs and treatment market segments, market trends and opportunities, and any further data you may need to thrive in the bipolar disorder drugs and treatment industry. This bipolar disorder drugs and treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bipolar disorder drugs and treatment market size has grown strongly in recent years. It will grow from $7.74 billion in 2024 to $8.24 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth observed in the historical period can be attributed to factors such as rising healthcare expenditures, increased research and funding for mental health, a growing number of healthcare professionals specializing in mental health, more early diagnoses of bipolar disorder, and an increasing demand for outpatient psychiatric care.
The bipolar disorder drugs and treatment market size is expected to see strong growth in the next few years. It will grow to $10.46 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The projected growth in the forecast period is driven by the rising global prevalence of bipolar disorder, greater awareness of mental health conditions, increasing acceptance of mental health treatment, broader insurance coverage for mental health care, and government initiatives aimed at improving mental health services. Key trends during this period include advancements in bipolar disorder drug development, improvements in diagnostic methods and tools, the introduction of new drug formulations, ongoing clinical trials and research on novel medications, and the availability of generic drugs for bipolar disorder.
The increasing prevalence of mental health disorders is expected to drive the growth of the bipolar disorder drugs and treatment market in the coming years. Mental health disorders are conditions that impact a person's thoughts, feelings, behavior, or mood, often hindering daily functioning and overall well-being. The rise in mental health disorders can be attributed to chronic stress stemming from modern lifestyles, with ongoing pressures related to work, finances, and social expectations negatively affecting emotional health and leading to long-term psychological challenges. Bipolar disorder drugs and treatments play a vital role in stabilizing mood fluctuations, improving emotional regulation, and reducing the frequency and severity of disruptive episodes associated with these disorders. For example, in September 2024, the National Institute of Mental Health (NIMH) reported that over 59.3 million adults in the US were affected by any mental illness (AMI) in 2022, which accounted for 23.1% of the adult population. Additionally, women were more likely than men to experience AMI, with 26.4% of women affected compared to 19.7% of men. As mental health disorders continue to rise, the demand for bipolar disorder drugs and treatments will grow.
Key players in the bipolar disorder drugs and treatment market are focusing on the development of advanced solutions such as extended-release injectable formulations, which offer consistent and long-term therapeutic effects. These formulations slowly release medication into the bloodstream over time, reducing the need for daily doses and ensuring stable therapeutic outcomes. For example, in January 2023, Luye Pharma, a China-based pharmaceutical company, received FDA approval for Rykindo (risperidone), a long-acting injectable treatment for adult schizophrenia and bipolar I disorder. This drug, which utilizes a unique microsphere technology platform developed by Luye Pharma, is administered via an intramuscular injection every two weeks, providing long-lasting effects. The active ingredient, risperidone, is delivered using the extended-release microsphere technology to ensure sustained release over time.
In April 2025, Johnson & Johnson, a US-based healthcare company, acquired Intra-Cellular Therapies Inc. for an undisclosed amount. This acquisition expands Johnson & Johnson's portfolio, adding CAPLYTA (lumateperone), a once-daily oral therapy approved for the treatment of schizophrenia and the first FDA-approved treatment for bipolar depression. The acquisition also includes ITI-1284, a promising Phase 2 compound being investigated for generalized anxiety disorder (GAD) and Alzheimer's disease-related psychosis and agitation. This deal strengthens Johnson & Johnson's clinical pipeline and supports its strategic focus on mental health and related therapeutic areas. Intra-Cellular Therapies Inc. is a US-based provider of bipolar disorder drugs and treatments.
Major players in the bipolar disorder drugs and treatment market are Pfizer Inc., Johnson & Johnson, Merch & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Astellas Pharma Inc., Sumitomo Pharma America Inc., Dr. Reddy's Laboratories Ltd., H. Lundbeck A/S, Cipla Limited, Gedeon Richter Plc, Lupin Limited, Neurocrine Biosciences Inc., and Alkermes Plc.
North America was the largest region in the bipolar disorder drugs and treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bipolar disorder drugs and treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the bipolar disorder drugs and treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bipolar disorder drugs and treatment market consists of revenues earned by entities by providing services such as research and development, medical consultation services, mental health counseling support, and telehealth services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bipolar disorder drugs and treatment market also includes sales of wearable monitoring devices, home diagnostic kits, cognitive assessment devices, and neurostimulation devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bipolar Disorder Drugs And Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bipolar disorder drugs and treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bipolar disorder drugs and treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bipolar disorder drugs and treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Bipolar Disorder Drugs And Treatment Market Characteristics
3. Bipolar Disorder Drugs And Treatment Market Trends And Strategies
4. Bipolar Disorder Drugs And Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Bipolar Disorder Drugs And Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Bipolar Disorder Drugs And Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bipolar Disorder Drugs And Treatment Market Growth Rate Analysis
5.4. Global Bipolar Disorder Drugs And Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bipolar Disorder Drugs And Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bipolar Disorder Drugs And Treatment Total Addressable Market (TAM)
6. Bipolar Disorder Drugs And Treatment Market Segmentation
6.1. Global Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mood Stabilizers
Anticonvulsants
Antipsychotic Drugs
Antidepressant Drugs
Anti-Anxiety Drugs
6.2. Global Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Routes Of Administration
6.3. Global Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bipolar I Disorder
Bipolar II Disorder
Cyclothymic Disorder
6.4. Global Bipolar Disorder Drugs And Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Bipolar Disorder Drugs And Treatment Market, Sub-Segmentation Of Mood Stabilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lithium Carbonate
Lamotrigine
Valproate
6.6. Global Bipolar Disorder Drugs And Treatment Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carbamazepine
Oxcarbazepine
Topiramate
6.7. Global Bipolar Disorder Drugs And Treatment Market, Sub-Segmentation Of Antipsychotic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Olanzapine
Risperidone
Quetiapine
Aripiprazole
6.8. Global Bipolar Disorder Drugs And Treatment Market, Sub-Segmentation Of Antidepressant Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.9. Global Bipolar Disorder Drugs And Treatment Market, Sub-Segmentation Of Anti-Anxiety Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Benzodiazepines
Buspirone
7. Bipolar Disorder Drugs And Treatment Market Regional And Country Analysis
7.1. Global Bipolar Disorder Drugs And Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bipolar Disorder Drugs And Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Bipolar Disorder Drugs And Treatment Market
8.1. Asia-Pacific Bipolar Disorder Drugs And Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Bipolar Disorder Drugs And Treatment Market
9.1. China Bipolar Disorder Drugs And Treatment Market Overview
9.2. China Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Bipolar Disorder Drugs And Treatment Market
10.1. India Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Bipolar Disorder Drugs And Treatment Market
11.1. Japan Bipolar Disorder Drugs And Treatment Market Overview
11.2. Japan Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Bipolar Disorder Drugs And Treatment Market
12.1. Australia Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Bipolar Disorder Drugs And Treatment Market
13.1. Indonesia Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Bipolar Disorder Drugs And Treatment Market
14.1. South Korea Bipolar Disorder Drugs And Treatment Market Overview
14.2. South Korea Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Bipolar Disorder Drugs And Treatment Market
15.1. Western Europe Bipolar Disorder Drugs And Treatment Market Overview
15.2. Western Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Bipolar Disorder Drugs And Treatment Market
16.1. UK Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Bipolar Disorder Drugs And Treatment Market
17.1. Germany Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Bipolar Disorder Drugs And Treatment Market
18.1. France Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Bipolar Disorder Drugs And Treatment Market
19.1. Italy Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Bipolar Disorder Drugs And Treatment Market
20.1. Spain Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Bipolar Disorder Drugs And Treatment Market
21.1. Eastern Europe Bipolar Disorder Drugs And Treatment Market Overview
21.2. Eastern Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Bipolar Disorder Drugs And Treatment Market
22.1. Russia Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Bipolar Disorder Drugs And Treatment Market
23.1. North America Bipolar Disorder Drugs And Treatment Market Overview
23.2. North America Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Bipolar Disorder Drugs And Treatment Market
24.1. USA Bipolar Disorder Drugs And Treatment Market Overview
24.2. USA Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Bipolar Disorder Drugs And Treatment Market
25.1. Canada Bipolar Disorder Drugs And Treatment Market Overview
25.2. Canada Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Bipolar Disorder Drugs And Treatment Market
26.1. South America Bipolar Disorder Drugs And Treatment Market Overview
26.2. South America Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Bipolar Disorder Drugs And Treatment Market
27.1. Brazil Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Bipolar Disorder Drugs And Treatment Market
28.1. Middle East Bipolar Disorder Drugs And Treatment Market Overview
28.2. Middle East Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Bipolar Disorder Drugs And Treatment Market
29.1. Africa Bipolar Disorder Drugs And Treatment Market Overview
29.2. Africa Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Bipolar Disorder Drugs And Treatment Market Competitive Landscape And Company Profiles
30.1. Bipolar Disorder Drugs And Treatment Market Competitive Landscape
30.2. Bipolar Disorder Drugs And Treatment Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merch & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Bipolar Disorder Drugs And Treatment Market Other Major And Innovative Companies
31.1. Sanofi S.A.
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca PLC
31.4. GSK PLC
31.5. Takeda Pharmaceutical Company Limited
31.6. Eli Lilly and Company
31.7. Teva Pharmaceutical Industries Ltd.
31.8. Boehringer Ingelheim International GmbH
31.9. Otsuka Holdings Co. Ltd.
31.10. Astellas Pharma Inc.
31.11. Sumitomo Pharma America Inc.
31.12. Dr. Reddy's Laboratories Ltd.
31.13. H. Lundbeck A/S
31.14. Cipla Limited
31.15. Gedeon Richter Plc
32. Global Bipolar Disorder Drugs And Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Bipolar Disorder Drugs And Treatment Market
34. Recent Developments In The Bipolar Disorder Drugs And Treatment Market
35. Bipolar Disorder Drugs And Treatment Market High Potential Countries, Segments and Strategies
35.1 Bipolar Disorder Drugs And Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Bipolar Disorder Drugs And Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Bipolar Disorder Drugs And Treatment Market In 2029 - Growth Strategies
